- Home
- SERA vs NVCT Comparison
SERA vs NVCT Comparison
Compare SERA & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- NVCT
- Stock Information
- Founded
- SERA 2008
- NVCT 2020
- Country
- SERA United States
- NVCT United States
- Employees
- SERA N/A
- NVCT N/A
- Industry
- SERA Precision Instruments
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- SERA Health Care
- NVCT Health Care
- Exchange
- SERA Nasdaq
- NVCT Nasdaq
- Market Cap
- SERA 142.9M
- NVCT 170.3M
- IPO Year
- SERA 2021
- NVCT 2022
- Fundamental
- Price
- SERA $3.68
- NVCT $9.77
- Analyst Decision
- SERA
- NVCT Strong Buy
- Analyst Count
- SERA 0
- NVCT 2
- Target Price
- SERA N/A
- NVCT $15.00
- AVG Volume (30 Days)
- SERA 105.6K
- NVCT 128.5K
- Earning Date
- SERA 03-19-2025
- NVCT 05-06-2025
- Dividend Yield
- SERA N/A
- NVCT N/A
- EPS Growth
- SERA N/A
- NVCT N/A
- EPS
- SERA N/A
- NVCT N/A
- Revenue
- SERA $77,000.00
- NVCT N/A
- Revenue This Year
- SERA $4,536.36
- NVCT N/A
- Revenue Next Year
- SERA $411.43
- NVCT N/A
- P/E Ratio
- SERA N/A
- NVCT N/A
- Revenue Growth
- SERA N/A
- NVCT N/A
- 52 Week Low
- SERA $3.33
- NVCT $4.44
- 52 Week High
- SERA $12.36
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- SERA 37.12
- NVCT 60.31
- Support Level
- SERA $3.77
- NVCT $8.45
- Resistance Level
- SERA $4.20
- NVCT $10.67
- Average True Range (ATR)
- SERA 0.24
- NVCT 0.99
- MACD
- SERA 0.01
- NVCT 0.08
- Stochastic Oscillator
- SERA 34.83
- NVCT 72.98
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.